serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| response to nutrient | ||
| blood coagulation | ||
| negative regulation of peptidase activity |
|
|
| regulation of blood coagulation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular space | ||
| extracellular space | ||
| extracellular space | ||
| collagen-containing extracellular matrix |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding | ||
| protease binding | ||
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:3755 | antithrombin III deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025